Impaired exercise performance in systemic sclerosis and its clinical correlations

Scandinavian Journal of Rheumatology

Volumn 39, Issue 4, 2010, Pages 330-335

  Cuomo, G ^a   Santoriello, C ^b   Polverino, F ^b   Ruocco, L ^a   Valentini, G ^a   Polverino, M ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b ASL SA/1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; LUNG FUNCTION TEST; MALE; OXYGEN CONSUMPTION; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RATING SCALE; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

ADULT; AGED; DISABILITY EVALUATION; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 77954878564     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009740903555358     Document Type: Article

References (41)

1. Seibold JR. Scleroderma. In: Harris ED, Budd RC, Firestein GS, editors. Kelley's textbook of rheumatology, 7th edn. Philadelphia, PA: Elsevier Saunders, 2005:1279-1308
2. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987;91:118-127
3. White B. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 2003:29;371-390
4. Denton CP, Black CM. Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am 2003:29;335-349
5. Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Polzleitner D, Burghuber OC, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755-759
6. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST variant of systemic sclerosis. Arthritis Rheum 1986;29:515-524
7. Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006;54:184-191
8. Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996;35:989-993
9. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985;55:22A-31A.
10. Harris-Eze AO, Sridhar G, Clemens RE, Zintel TA, Gallagher CG, Marciniuk DD. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. Am J Respir Crit Care Med 1996;154:994-1101.
11. Dautzker DR, D'Alonzo GE. Pulmonary gas exchange and exercise performance in pulmonary hypertension. Chest 1985;88:255S-7S.
12. Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 1994;150:1616-1622
13. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al. Effects of exercise training on LVF and peripheral resistance in patients with chronic heart failure: a randomized trial. J Am Med Assoc 2000;283:3095-3101
14. Hoeper MM, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J. Combination therapy with bosentan and sildenafil in idiopathic pulmonary hypertension. Eur Respir J 2004;24:107-110
15. Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Col- lop NA, et al. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993;95:413-418
16. Schwaiblamair M, Behr J, Fruhmann G. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996;110:1520-1525
17. Morelli S, Ferrante L, Sgreccia A, Eleuteri ML, Perrone C, De Marzio P, et al. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 2000;29:236-242
18. de Oliveira NC, dos Santos Sabbag LM, Ueno LM, de Souza RB, Borges CL, de Sa Pinto AL, et al. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol 2007;36:458-461
19. Ries MD, Philbin EF, Groff GD. Relationship between severity of gonarthrosis and cardiovascular fitness. Clin Orthop Relat Res 1995;313:169-176
20. Philbin EF, Groff GD, Ries MD, Miller TE. Cardiovascular fitness and health in patients with end-stage osteoarthritis. Arthritis Rheum 1995;38:799-805.
21. Carter R, Riantawan P, Banham SW, Sturrock RD. An investigation of factors limiting aerobic capacity in patients with ankylos- ing spondylitis. Respir Med 1999;93:700-708
22. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590
23. Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S. Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003;21(Suppl 29):S47-8.
24. Valentini G, Medsger TA Jr, Silman AJ. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc. Clin Exp Rheumatol 2003;21(Suppl 29):S49-56.
25. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205
26. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592-598
27. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21(Suppl 29):S42-6.
28. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4:27-31.
29. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136
30. Coates AL, Peslin R, Rodenstein D, Stocks J. Measurement of lung volumes by plethysmography. Eur Respir J 1997; 10:1415-1427
31. Blakemore WS, Forster RE, Morton JW, Ogilvie CM. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957;36:1-17.
32. Picillo U, Migliaresi S, Vatti M, Marcialis MR, Ferruzzi AM, Tirri G. Demographic differences in the frequencies of scleroderma- related autoantibodies. Arthritis Rheum 1992;35:216-218
33. Forte S, Carlone S, Vaccaro F, Onorati P, Manfredi F, Serra P, et al. Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus. J Rheumatol 1999;26:2591-2594
34. Kampolis C, Plaatiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G. The presence of anticentromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol 2008;37:278-283
35. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Pre-clinical Diabetic Cardiomyopathy: Relation of Left Ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Am J Cardiol 2000;85:473-477
36. Maione S, Cuomo G, Giunta A, Tanturri de Horatio L, La Montagna G, Manguso F, et al. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005;34:721-727
37. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-1991
38. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 2001;44:653-661
39. Sandqvist G, Hesselstrand R, Eberhardt K. A longitudinal follow- up of hand involvement and activities of daily living in early systemic sclerosis. Scand J Rheumatol 2009;38:304-310
40. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;169:441-447
41. Schoindre Y, Meune C, Dinh-Xuan AT, Avouac J, Kahan A, Allanore Y. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis. J Rheumatol 2009;36:1481-1485